Review
doi: 10.1055/s-2007-1004351.
From heparin to heparin fractions and derivatives
- PMID: 3883496
- DOI: 10.1055/s-2007-1004351
Item in Clipboard
Review
From heparin to heparin fractions and derivatives
Semin Thromb Hemost.
1985 Jan.
No abstract available
Similar articles
-
Heparin, its fractions, fragments and derivatives. Some newer perspectives.Semin Thromb Hemost. 1985 Jan;11(1):1-9. doi: 10.1055/s-2007-1004350. Semin Thromb Hemost. 1985. PMID: 3919446 Review.
-
An investigation of the functional role of the carboxylic groups of heparin. Affinity for antithrombin III and anti-Xa activity of selectively carboxyl esterified heparin.Semin Thromb Hemost. 1985 Jan;11(1):34-6. doi: 10.1055/s-2007-1004356. Semin Thromb Hemost. 1985. PMID: 3975640 No abstract available.
-
Development of heparin fractions: some overlooked considerations.Semin Thromb Hemost. 1985 Apr;11(2):227-36. doi: 10.1055/s-2007-1004380. Semin Thromb Hemost. 1985. PMID: 3898374 Review. No abstract available.
-
Rationale behind the development of low molecular weight heparin derivatives.Semin Thromb Hemost. 1985 Jan;11(1):13-6. doi: 10.1055/s-2007-1004352. Semin Thromb Hemost. 1985. PMID: 2579436 Review.
-
Molecular weight of heparin versus biologic activity. Some additional considerations.Semin Thromb Hemost. 1985 Jan;11(1):29-33. doi: 10.1055/s-2007-1004355. Semin Thromb Hemost. 1985. PMID: 2579437 Review. No abstract available.
Cited by
-
Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect.Nat Commun. 2024 Aug 8;15(1):6769. doi: 10.1038/s41467-024-50819-7. Nat Commun. 2024. PMID: 39117649 Free PMC article.
-
Low molecular weight heparins. An objective overview.Drugs Aging. 1992 Sep-Oct;2(5):406-22. doi: 10.2165/00002512-199202050-00005. Drugs Aging. 1992. PMID: 1327312 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
